Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation.
Yang JX, Chuang YC, Tseng JC, Liu YL, Lai CY, Lee AY, Huang CF, Hong YR, Chuang TH. J Exp Clin Cancer Res. 2024 Jun 17; 43(1):169. Epub 2024 Jun 17.